July 23, 2015 / 2:17 PM / in 2 years

BUZZ-Valeant Pharmaceuticals International Inc: Hits record high

** Canadian drugmaker’s U.S.-listed shares up about 4.2 pct at $249 after hitting record high of $252.79

** Toronto-listed stock rises 5.6 pct to hit record high of C$330

** Reports better-than-expected quarterly profit, helped by strength in its U.S. dermatology business

** Raises 2015 forecast to reflect sales of recently acquired Salix Pharmaceuticals’ irritable bowel syndrome drug, Xifaxan

** Up to Wednesday’s close, U.S-listed stock had risen about 21 pct since March 16, when Valeant trumped Endo International Plc for Salix

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below